Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6851580 | 0.89 | MCL1 (0.32) | HTR2AHTR2C | |
| SCHEMBL6852208 | 0.88 | HTR2A (0.31) | HTR2AHTR2C | |
| SCHEMBL7674690 | 0.87 | PTGDR (0.31) | — | |
| SCHEMBL7676778 | 0.83 | HTR2C (0.37) | HTR2AHTR2C | |
| SCHEMBL6484031 | 0.82 | PTGDR2 (0.47) | — | |
| SCHEMBL7679724 | 0.81 | HTR2A (0.36) | HTR2AHTR2C | |
| Maleic Acid SCHEMBL6484778 | 0.79 | HTR2C (0.43) | HTR2AHTR2C | |
| Fumaric Acid SCHEMBL6484785 | 0.79 | HTR2C (0.43) | HTR2AHTR2C | |
| SCHEMBL7673368 | 0.79 | HTR2C (0.41) | HTR2AHTR2C | |
| SCHEMBL7673579 | 0.79 | HTR2A (0.38) | RIPK1HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020198190-A1 | Tetracyclic azepinoindole compounds | PHARMACIA & UPJOHN COMPANY | 2002-12-26 | — | — | US | claimed |
| US-20020198190-A1 | Tetracyclic azepinoindole compounds | PHARMACIA & UPJOHN COMPANY | 2002-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020198190-A1 | Tetracyclic azepinoindole compounds | TPH1, AZI2, CYP1A2 | MAPT 2518/4885TSHR 334/4885RIPK1 4514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.